REVIEW article
Front. Oncol.
Sec. Cancer Molecular Targets and Therapeutics
CD44 Targeted Functionalized Nanocarriers for Non-Small Cell Lung Cancer
Provisionally accepted
- 1Yantai Yantaishan Hospital, Yantai, China
- 2The Central Hospital of Zibo, Zibo, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Non-small cell lung cancer (NSCLC) is a significant worldwide health concern, requiring novel treatment strategies. This review presents the potential of CD44-targeted functionalized nanocarriers as effective tools for treating NSCLC. CD44, a glycoprotein found on surface of cells, is known for being excessively expressed in NSCLC, making it a promising target for targeted drug delivery. The review begins by examining CD44 as a crucial biomarker in NSCLC. The text provides an overview of molecular features of NSCLC. These fundamental concepts provide the framework for comprehending the reasoning behind the focused strategy of medication delivery using nanocarriers. The review discusses the importance of key factors, such as the dimensions, morphology, and electrostatic properties of nanocarriers, in relation to their influence on interactions with CD44 receptors. The review provides an assessment of preclinical and clinical research that has examined the use of CD44-targeted nanocarriers in the treatment of NSCLC. The review further provides an analysis of safety concerns and possible difficulties, like immunogenicity and off-target effects, in relation to CD44-targeted nanocarriers. This review provides helpful guidance to researchers and clinicians who are interested in using CD44-targeted nanocarriers for more precise and efficient therapies of NSCLC.
Keywords: Non-small cell lung cancer, CDD44, biomarker, Drug delivery, nanocarriers
Received: 26 Aug 2025; Accepted: 28 Oct 2025.
Copyright: © 2025 Zhu, Guo, Jiang and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mingling Xu, 18560292001@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.